sodium arsenite has been researched along with Biliary Tract Cancer in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bang, S; Chung, MJ; Jo, JH; Kang, H; Lee, HS; Park, JY; Park, SW; Song, SY | 1 |
1 other study(ies) available for sodium arsenite and Biliary Tract Cancer
Article | Year |
---|---|
KML001, an arsenic compound, as salvage chemotherapy in refractory biliary tract cancers: A prospective study.
Topics: Administration, Oral; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Arsenites; Biliary Tract Neoplasms; Deoxycytidine; Drug Administration Schedule; Drug Resistance, Neoplasm; Female; Gemcitabine; Humans; Male; Middle Aged; Progression-Free Survival; Prospective Studies; Salvage Therapy; Sodium Compounds; Time Factors; Tomography, X-Ray Computed | 2019 |